Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registrySalah‐Eddin Al‐Batran, Ursula Vehling‐Kaiser, Caroline Schönherr et al.|International Journal of Cancer|2020Cited by 21
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)Frank Griesinger, Dimitri Flieger, Wilfried Eberhardt et al.|JTO Clinical and Research Reports|2023Cited by 4